Insider Transactions in Q4 2021 at Broadridge Financial Solutions, Inc. (BR)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
Dec 28
2021
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
415
-0.64%
|
$76,775
$185.04 P/Share
|
Dec 28
2021
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
466
+0.71%
|
$45,668
$98.31 P/Share
|
Dec 15
2021
|
Keir D Gumbs CVP and Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,886
-48.1%
|
$691,708
$178.02 P/Share
|
Dec 15
2021
|
Keir D Gumbs CVP and Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,079
+50.0%
|
-
|
Dec 07
2021
|
Robert Schifellite Corporate SVP |
SELL
Open market or private sale
|
Direct |
18,063
-12.87%
|
$3,124,899
$173.26 P/Share
|
Dec 07
2021
|
Robert Schifellite Corporate SVP |
BUY
Exercise of conversion of derivative security
|
Direct |
18,040
+19.89%
|
$902,000
$50.95 P/Share
|
Dec 06
2021
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
162
+2.0%
|
-
|
Dec 06
2021
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
184
+0.83%
|
-
|
Dec 06
2021
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
162
+20.02%
|
-
|
Dec 06
2021
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
153
+4.03%
|
-
|
Dec 03
2021
|
Robert Schifellite Corporate SVP |
SELL
Open market or private sale
|
Direct |
12,488
-18.61%
|
$2,160,424
$173.11 P/Share
|
Dec 03
2021
|
Robert Schifellite Corporate SVP |
BUY
Exercise of conversion of derivative security
|
Direct |
14,960
+18.23%
|
$748,000
$50.95 P/Share
|
Nov 29
2021
|
Vijay Mayadas Corporate Vice President |
SELL
Open market or private sale
|
Direct |
25,208
-9.29%
|
$4,386,192
$174.0 P/Share
|
Nov 29
2021
|
Vijay Mayadas Corporate Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
28,836
+9.71%
|
$2,278,044
$79.96 P/Share
|
Nov 18
2021
|
Leslie A Brun Director |
BUY
Grant, award, or other acquisition
|
Direct |
649
+1.1%
|
-
|
Nov 18
2021
|
Pamela L Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
485
+12.8%
|
-
|
Nov 18
2021
|
Robert N Duelks Director |
BUY
Grant, award, or other acquisition
|
Direct |
485
+1.53%
|
-
|
Nov 18
2021
|
Melvin L Flowers Director |
BUY
Grant, award, or other acquisition
|
Direct |
485
+50.0%
|
-
|
Nov 18
2021
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
485
+5.88%
|
-
|
Nov 18
2021
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
485
+2.19%
|
-
|
Nov 18
2021
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
485
+50.0%
|
-
|
Nov 18
2021
|
Thomas J Perna Director |
BUY
Grant, award, or other acquisition
|
Direct |
485
+0.96%
|
-
|
Nov 18
2021
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
485
+12.21%
|
-
|
Nov 18
2021
|
Leslie A Brun Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,113
+22.86%
|
$359,373
$21.29 P/Share
|
Nov 10
2021
|
Michael S Tae Corporate VP, CTO, ICS |
SELL
Open market or private sale
|
Direct |
34,556
-21.25%
|
$6,150,968
$178.53 P/Share
|
Nov 10
2021
|
Michael S Tae Corporate VP, CTO, ICS |
BUY
Exercise of conversion of derivative security
|
Direct |
36,309
+18.06%
|
$3,521,973
$97.66 P/Share
|
Oct 19
2021
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
10,104
-13.53%
|
$1,818,720
$180.14 P/Share
|
Oct 19
2021
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
11,519
+13.36%
|
$1,071,267
$93.88 P/Share
|
Oct 15
2021
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
902
-1.41%
|
$162,360
$180.01 P/Share
|
Oct 15
2021
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,016
+1.56%
|
$94,488
$93.88 P/Share
|
Oct 07
2021
|
Richard J Daly Executive Chairman |
SELL
Open market or private sale
|
Direct |
73,300
-33.13%
|
$12,314,400
$168.43 P/Share
|
Oct 07
2021
|
Richard J Daly Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
81,909
+14.66%
|
$7,863,264
$96.09 P/Share
|
Oct 06
2021
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+2.09%
|
-
|
Oct 06
2021
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+0.73%
|
-
|
Oct 06
2021
|
Alan J Weber Director |
BUY
Grant, award, or other acquisition
|
Direct |
177
+0.24%
|
-
|
Oct 06
2021
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
145
+4.61%
|
-
|
Oct 06
2021
|
Richard J Daly Executive Chairman |
SELL
Open market or private sale
|
Direct |
92,009
-20.16%
|
$15,181,485
$165.5 P/Share
|
Oct 06
2021
|
Richard J Daly Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
102,847
+15.96%
|
$8,227,760
$80.6 P/Share
|
Oct 05
2021
|
Richard J Daly Executive Chairman |
SELL
Open market or private sale
|
Direct |
77,661
-20.9%
|
$12,736,404
$164.02 P/Share
|
Oct 05
2021
|
Richard J Daly Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
39,000
+15.91%
|
$2,613,000
$67.32 P/Share
|
Oct 05
2021
|
Leslie A Brun Director |
BUY
Grant, award, or other acquisition
|
Direct |
95
+0.23%
|
-
|
Oct 05
2021
|
Pamela L Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.35%
|
-
|
Oct 05
2021
|
Robert N Duelks Director |
BUY
Grant, award, or other acquisition
|
Direct |
66
+0.21%
|
-
|
Oct 05
2021
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
50
+0.12%
|
-
|
Oct 05
2021
|
Thomas J Perna Director |
BUY
Grant, award, or other acquisition
|
Direct |
66
+0.13%
|
-
|
Oct 05
2021
|
Alan J Weber Director |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.05%
|
-
|
Oct 05
2021
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.17%
|
-
|
Oct 05
2021
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
26
+0.18%
|
-
|
Oct 01
2021
|
Michael S Tae Corporate VP, CTO, ICS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,619
-26.5%
|
$434,754
$166.02 P/Share
|
Oct 01
2021
|
Michael S Tae Corporate VP, CTO, ICS |
BUY
Exercise of conversion of derivative security
|
Direct |
4,928
+33.27%
|
-
|